Evidence map›Paper›PMID 7623828›Full record

ArticleMolecular and cellular biology1995

A functional T-cell receptor signaling pathway is required for p95vav activity.

J Wu, S Katzav, A Weiss

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 170 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Vav2 lacks CaJournal of cell science · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Review
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

J WuDepartment of Microbiology and Immunology, University of California, San Francisco 94143, USA.
S Katzav
A Weiss
Howard Hughes Medical Institute · USJewish General Hospital · CAUniversity of California, San Francisco · US

Funding

FUNCTION OF THE HUMAN CD28 MOLECULER01GM044493 · NIGMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WEISS, ARTHUR · 1992 to 1995
–
NIGMS NIH HHS GM 44493
6 · The paper itself

Abstract

Stimulation of the T-cell antigen receptor (TCR) induces activation of multiple tyrosine kinases, resulting in phosphorylation of numerous intracellular substrates. One substrate is p95vav, which is expressed exclusively in hematopoietic and trophoblast cells. It contains a number of structural motifs, including Src homology 2, Src homology 3, and pleckstrin homology domains and a putative guanine nucleotide exchange domain. The role of p95vav in TCR-mediated signaling processes is unclear. Here, we show that overexpression of p95vav alone in Jurkat T cells leads to activation of the nuclear factors, including NFAT, involved in interleukin-2 expression. Furthermore, p95vav synergizes with TCR stimulation in inducing NFAT- and interleukin-2-dependent transcription. In contrast, NFAT activation by a G-protein-coupled receptor is not modulated by p95vav overexpression, suggesting that the effect is specific to the TCR signaling pathways. Although removal of the first 67 amino acids of p95vav activates its transforming potential in NIH 3T3 cells, this region appears to be required for its function in T cells. We further demonstrate that the p95vav-induced NFAT activation is not mimicked by Ras activation, though its function is dependent upon Ras and Raf. Furthermore, the activating function of p95vav is blocked by FK506, suggesting that its activity also depends on calcineurin. To further dissect p95vav involvement in TCR signaling, we analyzed various Jurkat mutants deficient in TCR signaling function or TCR expression and showed that an intact TCR signaling pathway is required for p95vav to function. However, overexpression of p95vav does not appear to influence TCR-induced protein tyrosine phosphorylation or increases in cytoplasmic free calcium. Taken together, our data suggest that p95vav plays an important role at an yet unidentified proximal position in the TCR signaling cascade.

Indexed as

Cell Cycle ProteinsNuclear ProteinsSignal TransductionCalcineurinCalciumCalmodulin-Binding ProteinsDNA-Binding ProteinsGTP-Binding ProteinsHumansInterleukin-2NFATC Transcription FactorsOncogene ProteinsPhosphoprotein PhosphatasesPromoter Regions, GeneticProto-Oncogene ProteinsProto-Oncogene Proteins c-vavCalcineurinCalciumCalmodulin-Binding ProteinsCell Cycle ProteinsDNA-Binding ProteinsGTP-Binding ProteinsInterleukin-2NFATC Transcription FactorsNuclear ProteinsOncogene ProteinsPhosphoprotein PhosphatasesProto-Oncogene ProteinsProto-Oncogene Proteins c-vavras ProteinsReceptors, Antigen, T-CellRecombinant ProteinsTranscription FactorsVAV1 protein, human

Identifiers

PMID7623828
PMCPMC230673
OpenAlexW2104069123

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.